RU2622644C2 - Кристаллическое вещество и содержащий его фармацевтический препарат - Google Patents

Кристаллическое вещество и содержащий его фармацевтический препарат Download PDF

Info

Publication number
RU2622644C2
RU2622644C2 RU2015113638A RU2015113638A RU2622644C2 RU 2622644 C2 RU2622644 C2 RU 2622644C2 RU 2015113638 A RU2015113638 A RU 2015113638A RU 2015113638 A RU2015113638 A RU 2015113638A RU 2622644 C2 RU2622644 C2 RU 2622644C2
Authority
RU
Russia
Prior art keywords
crystalline substance
luliconazole
pharmaceutical preparation
crystalline
complex
Prior art date
Application number
RU2015113638A
Other languages
English (en)
Russian (ru)
Other versions
RU2015113638A (ru
Inventor
Такааки МАСУДА
Макото ГОТОХ
Йосиюки МИЯТА
Original Assignee
Пола Фарма Инк.
Нихон Нохияку Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пола Фарма Инк., Нихон Нохияку Ко., Лтд. filed Critical Пола Фарма Инк.
Publication of RU2015113638A publication Critical patent/RU2015113638A/ru
Application granted granted Critical
Publication of RU2622644C2 publication Critical patent/RU2622644C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU2015113638A 2012-09-14 2013-09-06 Кристаллическое вещество и содержащий его фармацевтический препарат RU2622644C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2012-202514 2012-09-14
JP2012202514 2012-09-14
JP2013131504 2013-06-24
JP2013-131504 2013-06-24
PCT/JP2013/074775 WO2014042231A1 (en) 2012-09-14 2013-09-06 Crystal and pharmaceutical preparation containing the same crystal

Publications (2)

Publication Number Publication Date
RU2015113638A RU2015113638A (ru) 2016-11-10
RU2622644C2 true RU2622644C2 (ru) 2017-06-19

Family

ID=49237577

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015113638A RU2622644C2 (ru) 2012-09-14 2013-09-06 Кристаллическое вещество и содержащий его фармацевтический препарат

Country Status (7)

Country Link
US (1) US9012484B2 (enExample)
EP (1) EP2895165B1 (enExample)
JP (1) JP5589130B1 (enExample)
CN (1) CN104284662A (enExample)
IN (1) IN2015DN02929A (enExample)
RU (1) RU2622644C2 (enExample)
WO (1) WO2014042231A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2011024620A1 (en) 2009-08-25 2011-03-03 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5832451B2 (ja) 2010-06-11 2015-12-16 株式会社ポーラファルマ 抗真菌医薬組成物
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
WO2014041708A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) * 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
EP3230280A4 (en) 2014-12-12 2018-05-09 Glenmark Pharmaceuticals Limited Process for preparation of luliconazole
JP5951864B1 (ja) * 2015-06-05 2016-07-13 株式会社ポーラファルマ 抗ジアルジア剤
JP2017101009A (ja) 2015-12-04 2017-06-08 株式会社ポーラファルマ 抗アカントアメーバ剤及びその製造法
TR201714882A2 (tr) 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
JP7251578B2 (ja) * 2021-08-18 2023-04-04 カシオ計算機株式会社 電子機器

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002821A2 (en) * 1995-07-08 1997-01-30 Nihon Nohyaku Co., Ltd. Antifungal agent, compound therefor, process for producing the same
WO2007102241A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
RU2008139904A (ru) * 2006-03-08 2010-04-20 Нихон Нохияку Ко.,Лтд. (Jp) Фармацевтическая композиция для наружного применения

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
JP3278738B2 (ja) 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
MX2008011435A (es) 2006-03-08 2009-02-03 Nihon Nohyaku Co Ltd Composicion farmaceutica para uso externo.
JP5529539B2 (ja) * 2007-09-05 2014-06-25 株式会社ポーラファルマ 医薬組成物
JP5453093B2 (ja) * 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
JP5345937B2 (ja) 2007-09-05 2013-11-20 株式会社ポーラファルマ 抗真菌組成物
CN102395274B (zh) 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2011024620A1 (en) 2009-08-25 2011-03-03 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5832451B2 (ja) 2010-06-11 2015-12-16 株式会社ポーラファルマ 抗真菌医薬組成物
US8728210B2 (en) 2011-07-07 2014-05-20 Hsueh Yuan Lee Exhaust gas treatment apparatus and method
CN103012385B (zh) 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
WO2014041708A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
EP2895164A1 (en) 2012-09-14 2015-07-22 Pola Pharma Inc. Pharmaceutical composition containing luliconazole
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002821A2 (en) * 1995-07-08 1997-01-30 Nihon Nohyaku Co., Ltd. Antifungal agent, compound therefor, process for producing the same
WO2007102241A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
RU2008139904A (ru) * 2006-03-08 2010-04-20 Нихон Нохияку Ко.,Лтд. (Jp) Фармацевтическая композиция для наружного применения

Also Published As

Publication number Publication date
RU2015113638A (ru) 2016-11-10
EP2895165B1 (en) 2016-12-14
EP2895165A1 (en) 2015-07-22
JP2015027972A (ja) 2015-02-12
WO2014042231A1 (en) 2014-03-20
US20140080882A1 (en) 2014-03-20
CN104284662A (zh) 2015-01-14
JP5589130B1 (ja) 2014-09-10
US9012484B2 (en) 2015-04-21
IN2015DN02929A (enExample) 2015-09-18

Similar Documents

Publication Publication Date Title
EP2895165B1 (en) Crystal and pharmaceutical preparation containing the same crystal
RU2603963C2 (ru) Кристалл, обладающий кристаллическими габитусами, и фармацевтическая композиция, полученная обработкой данного кристалла
CN111372920B (zh) N-(4-(4-(环丙基甲基)哌嗪-1-羰基)苯基)喹啉-8-磺酰胺的结晶形式
EP2964641B1 (en) Crystalline form having specific crystal habit and pharmaceutical composition containing this crystalline form as active ingredient
CN101485625B (zh) 阿莫罗芬乳膏
US20180064685A1 (en) Cancer treatment composition
CN103553996B (zh) 抗胆碱药物组合物
JP7848227B2 (ja) タンパク質キナーゼ阻害剤としてのヘテロ環化合物の新規塩およびこれらの用途
EP3041837B1 (en) Crystal having specific crystal habit and pharmaceutical composition containing the crystal as active ingredient
JP5795694B2 (ja) 結晶及び該結晶を含有してなる医薬製剤
CN110269854A (zh) 桑根酮c的医药新用途
JP5795693B2 (ja) 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
WO2018115319A2 (en) Inhibitors of cytochrome p450 family 7 subfamily b member 1 (cyp7b1) for use in treating diseases
TWI749435B (zh) 促進膽固醇代謝相關基因表現之化合物之用途
CA3247908A1 (en) PHARMACEUTICAL COMPOSITION COMPRISING A NEUROKIN-1 ANTAGONIST PROMEDICINE COMPOUND
HK1223568B (en) Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation